James O'Shaughnessy
4K posts
@jamesosh
Senior Partner https://t.co/0uYmyTykZR // Visiting Prof. @Imperial_IGHI // Non-Exec @HDR_UK & @albionvc // HMG Review of Clinical Trials https://t.co/1L6qHmG4UQ
EXCL - Ministers have cut funding for Armed Forces cadet training in schools - as the country prepares to mark Remembrance Day thesun.co.uk/news/politics/…
Pleased to see HM Govt is keeping up momentum on my Clinical Trials Review, including the ‘double-doubling’ ambition. MHRA is performing much better, moving to a national approach to contracting and costing, and the number of industry-sponsored trials in the UK is growing again.
The full government response to the @jamesosh review has been published. It emphasises our commitment to maintaining a rich and balanced research portfolio that delivers impactful #research to improve health for patients and the public. gov.uk/government/pub…
‘Until now, the approach has primarily been to ask for forgiveness, rather than permission. Unless that changes then public scepticism will scupper one of the UK’s most exciting health and economic opportunities.’ 🖊️ @sairaghafur and @jamesosh #Echobox=1692270694-1" target="_blank" rel="nofollow noopener">newstatesman.com/spotlight/heal…
I love my job but today was hard: telling a patient who will die of his cancer that I can’t offer a promising clinical trial because an amendment has been stuck with the MHRA since March. This is not good enough and I wonder if my MP would like to come to my clinic and explain?
Thank you for your support @jamesosh "Daniel is full of ideas, energy and has the practical experience that counts from business, diplomacy and politics - which is exactly what London needs" - Lord James O'Shaughnessy
Dementia is one of the greatest health challenges facing our society & the NHS today — but historically has received less attention, funding & resources than other conditions. It's time to "turn the tide" on dementia research writes @jamesosh👇 bit.ly/403KXYO
